# Temocillin Versus Carbapenems for Urinary Tract Infection Due to ESBL-producing Enterobacteriaceae

> **NCT04671290** · — · COMPLETED · sponsor: **Centre Hospitalier Annecy Genevois** · enrollment: 144 (actual)

## Conditions studied

- Urinary Tract Infection Bacterial

## Interventions

- **OTHER:** Any intervention

## Key facts

- **NCT ID:** NCT04671290
- **Lead sponsor:** Centre Hospitalier Annecy Genevois
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-01
- **Primary completion:** 2019-10-31
- **Final completion:** 2019-10-31
- **Target enrollment:** 144 (ACTUAL)
- **Last updated:** 2020-12-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04671290

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04671290, "Temocillin Versus Carbapenems for Urinary Tract Infection Due to ESBL-producing Enterobacteriaceae". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04671290. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*